共 36 条
[1]
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
[J].
BMJ-BRITISH MEDICAL JOURNAL,
1994, 308 (6921)
:81-100
[3]
EFFECT OF PROPRANOLOL VERSUS NO ANTIARRHYTHMIC DRUG ON SUDDEN CARDIAC DEATH, TOTAL CARDIAC DEATH, AND TOTAL DEATH IN PATIENTS GREATER-THAN-OR-EQUAL-TO-62-PERCENT YEARS OF AGE WITH HEART-DISEASE, COMPLEX VENTRICULAR ARRHYTHMIAS, AND LEFT-VENTRICULAR EJECTION FRACTION GREATER-THAN-OR-EQUAL-TO-40-PERCENT
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1994, 74 (03)
:267-270
[4]
Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction >=40% treated with diuretics plus angiotensin-converting enzyme inhibitors
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1997, 80 (02)
:207-209
[7]
BALL SG, 1993, LANCET, V342, P821
[8]
Blackshear JL, 1996, LANCET, V348, P633
[9]
FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707

